Belvedere Trading’s Amgen AMGN Stock Holding History

Belvedere Trading’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-17,120	Closed	-$2.73M	–	32
2014 Q4	$2.73M	Buy	+17,120	New	+$2.67M	0.02%	51

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Belvedere Trading's AMGN Position: Q1 2015 in Review

Belvedere Trading sold out of Amgen (AMGN) in Q1 2015, closing a stake of 17,120 shares — an estimated $2.73M sold.

Belvedere Trading first reported a position in AMGN in Q4 2014 and held it in 1 quarter. The position peaked at $2.73M in Q4 2014. 1,344 funds tracked by Wall St. Rank hold AMGN as of Q1 2015.

Belvedere Trading reported no remaining Amgen position as of Q1 2015 after selling out during the quarter.
Belvedere Trading sold 17,120 Amgen shares in Q1 2015, an estimated $2.73M.
Belvedere Trading first reported a position in Amgen in Q4 2014 and held it in 1 quarter.
Belvedere Trading's Amgen position peaked at $2.73M in Q4 2014.
1,344 funds tracked by Wall St. Rank held Amgen as of Q1 2015.

Based on Belvedere Trading's 13F filing for Q1 2015, filed 14 May 2015.